Next Generation Sequencing (NGS)

Cancer/Leukemia

Next Generation Sequencing (NGS)

Next-generation sequencing (NGS) is a technology that enables sequencing of multiple regions of the genome in a single assay. Compared to “traditional” or Sanger sequencing method, NGS allows sequencing at higher coverage levels (deep sequencing) that result in greater confidence for calling low-frequency variants. Our targeted NGS panels are designed to detect mutations, substitutions, insertions, and deletions that may have diagnostic, prognostic, and/or therapeutic implications in hematologic malignancies.